Viagra Label Will Add Language On Blindness Incidence “In Near Future”
Executive Summary
Pfizer expects to update Viagra labeling "in the near future" to reflect data on the incidence of vision loss in patients receiving the erectile dysfunction therapy
You may also be interested in...
Viagra Label Change Delay Shows Need For Safety Reform – Sen. Grassley
FDA's response to reports of vision loss in Viagra patients is being cited by Senate Finance Committee Chairman Charles Grassley (R-Iowa) as another reason to reform the agency's drug safety system
Viagra Label Change Delay Shows Need For Safety Reform – Sen. Grassley
FDA's response to reports of vision loss in Viagra patients is being cited by Senate Finance Committee Chairman Charles Grassley (R-Iowa) as another reason to reform the agency's drug safety system
Viagra’s Second Wind: Pfizer Revatio Approved For Pulmonary Hypertension
Pfizer's post-marketing commitments for Revatio include submitting a plan to educate health care providers that the pulmonary arterial hypertension therapy has the same active ingredient as the erectile dysfunction drug Viagra